Home News Allergy and Asthma News Death Count Climbs in Outbreak Linked to Recalled Eye Drops

Death Count Climbs in Outbreak Linked to Recalled Eye Drops

CDC says infections with Pseudomonas aeruginosa have led to two additional deaths

By Physician’s Briefing Staff HealthDay Reporter

WEDNESDAY, March 22, 2023 (HealthDay News) — A drug-resistant bacteria linked to recalled eye drops has now killed three people.

The U.S. Centers for Disease Control and Prevention reported Tuesday that infections with Pseudomonas aeruginosa had led to two additional deaths. In all, 68 people have become infected in 16 states. Eight of the patients have lost their vision. Four people have had to have their eyeballs removed.

Three eye products have been recalled from Global Pharma Healthcare Private Limited in India. They were sold online and at stores and provided through ophthalmologist offices.

While the P. aeruginosa strain involved in the recalls is resistant to 12 antibiotics, there may be new hope for treating it. Researchers at the University of California, San Diego, say they have identified a bacteriophage that has potential for working on the bacteria, CBS News reported.

The university’s Center for Innovative Phage Applications has previously reported on therapies it developed to save patients with drug-resistant infections, CBS News reported. The center did not immediately respond to request for comment from CBS News. It is not known how many patients have been treated with the phage identified for this bacteria.

In unrelated contamination incidents, two additional eye products from other manufacturers have been recently recalled, CBS News reported.

CBS News Article

Copyright © 2023 HealthDay. All rights reserved.